Form 4: Edwards Lifesciences Director Kieran Gallahue Reports Stock Grants in Form 4 Filing

Director Kieran Gallahue reported the acquisition of common stock through restricted stock units and awards granted under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program.

Summary

• Kieran Gallahue, a director of Edwards Lifesciences Corp, filed a Form 4 with the SEC on May 9, 2025.
• The filing reports the acquisition of 3,528 shares of common stock through restricted stock units and 1,154 shares through a restricted stock award, both granted on May 9, 2025.
• These grants were made under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program.
• The restricted stock units and award are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.
• Following these transactions, Gallahue directly owns 4,682 shares of common stock and indirectly owns 74,974 shares through a trust.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment, but rather reports factual information about stock transactions.

Positives

• The grants of restricted stock units and awards align the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The restricted stock units and awards will vest after one year or at the next annual meeting, incentivizing the director's continued service.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders, such as directors and officers, in their company's stock. This allows investors to monitor insider activity, which can provide insights into management's perspective on the company's performance and future prospects.

Stakeholder Impact

• Shareholders may view the stock grants as a positive sign, aligning the director's interests with the company's performance.
• Employees may see the grants as a sign of the company's commitment to its leadership.

Key Dates

Keywords

Form 4, Edwards Lifesciences, Director, Kieran Gallahue, Stock Incentive Program, Restricted Stock Units, Restricted Stock Award, Beneficial Ownership